Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Dosing of 5-FU in Head & Neck Cancer
NCT02484677Phase 4Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jul 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorouracil in head and neck cancer (HNC), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Jul 2015; status: completed.
02
Drugs
fluorouracil
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT02484677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484677.